UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042427
Receipt number R000048438
Scientific Title A Study on skin improving effects of a pseudo-ceramide containing formulation for sensitive skin
Date of disclosure of the study information 2020/11/16
Last modified on 2020/11/12 15:29:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of a pseudo-ceramide containing formulation

Acronym

Evaluation of a pseudo-ceramide containing formulation

Scientific Title

A Study on skin improving effects of a pseudo-ceramide containing formulation for sensitive skin

Scientific Title:Acronym

Evaluation of a pseudo-ceramide containing formulation

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the efficacy of a pseudo-ceramide formulation on the skin of healthy females

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of transepidermal water loss, stratum corneum water content and dermatological assessment after treatments for 1 or 2 weeks.

Key secondary outcomes

Evaluation of the skin surface images, questionnaire survey and VAS after treatments for 1 or 2 weeks.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply the water based model lotion and the model emulsion on facial skin twice a day for a week.
After that, apply the pseudo-ceramide containing formulation in addition to above model lotions and emulsion once a day for 2 weeks.

Interventions/Control_2

Apply the water based model lotion and the model emulsion on facial skin twice a day for three weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Female

Key inclusion criteria

1. Females who are 20-59 years old
2. Subjects who have sensitive skin consciousness.
3. Subjects who have dry skin consciousness.
4. Subjects who apply to one or more following questions.
a. I need to use skin care products twice a day on my face.
b. Cosmetics and medicines have caused redness, drying and irritation to my skin.
c. I use cosmetic products for sensitive skin.
5. Subjects who use face wash at least 5 days a week
6. Subjects who use lotion or all-in-one cosmetics at least 5 days a week

Key exclusion criteria

1. Subjects who are pregnancy, lactation, or subjects who may become pregnant very soon.
2. Subjects with serious underlying diseases.
3. Subjects who have clear skin symptoms at the test site.
4. Subjects who are currently undergoing hospital treatment with atopic dermatitis
5. Subjects who have had atopic dermatitis symptoms in their face within the present or past year
6. Subjects who are currently treating the skin of the face
7. Subjects who are currently using external drugs (prescription drugs, over-the-counter drugs) on the skin of the face
8. Subjects who are currently participating in product monitor surveys involving testing of the use of other drugs or with the use of quasi-drugs, cosmetics, and facial devices
9. Subjects who are determined to be not appropriate by investigator.

Target sample size

55


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Kaizu

Organization

Kao Corporation

Division name

R&D Skin Care Products Research

Zip code

250-0002

Address

5-3-28, Kotobukicho, Odawara, Kanagawa, 250-0002, Japan

TEL

0465-34-0559

Email

kaizu.kazuhiro@kao.com


Public contact

Name of contact person

1st name Seri
Middle name
Last name Akiyama

Organization

Kao Corporation

Division name

R&D Skin Care Products Research

Zip code

250-0002

Address

5-3-28, Kotobukicho, Odawara, Kanagawa, 250-0002, Japan

TEL

0465-34-0559

Homepage URL


Email

akiyama.seri@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社セブンオーワンリサーチ(東京都)


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

55

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 09 Month 24 Day

Date of IRB

2020 Year 09 Month 24 Day

Anticipated trial start date

2020 Year 11 Month 04 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 12 Day

Last modified on

2020 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name